1 Study Coverage
1.1 Artemisinine Product Introduction
1.2 Market by Type
1.2.1 Global Artemisinine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Extraction from Artemisia annua
1.2.3 Semisynthetic Artemisinine
1.3 Market by Application
1.3.1 Global Artemisinine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Injections
1.3.3 Tablets
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Artemisinine Sales Estimates and Forecasts 2017-2028
2.2 Global Artemisinine Revenue Estimates and Forecasts 2017-2028
2.3 Global Artemisinine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Artemisinine Sales by Region
2.4.1 Global Artemisinine Sales by Region (2017-2022)
2.4.2 Global Sales Artemisinine by Region (2023-2028)
2.5 Global Artemisinine Revenue by Region
2.5.1 Global Artemisinine Revenue by Region (2017-2022)
2.5.2 Global Artemisinine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Artemisinine Sales by Manufacturers
3.1.1 Global Top Artemisinine Manufacturers by Sales (2017-2022)
3.1.2 Global Artemisinine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Artemisinine in 2021
3.2 Global Artemisinine Revenue by Manufacturers
3.2.1 Global Artemisinine Revenue by Manufacturers (2017-2022)
3.2.2 Global Artemisinine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Artemisinine Revenue in 2021
3.3 Global Artemisinine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Artemisinine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Artemisinine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Artemisinine Sales by Type
4.1.1 Global Artemisinine Historical Sales by Type (2017-2022)
4.1.2 Global Artemisinine Forecasted Sales by Type (2023-2028)
4.1.3 Global Artemisinine Sales Market Share by Type (2017-2028)
4.2 Global Artemisinine Revenue by Type
4.2.1 Global Artemisinine Historical Revenue by Type (2017-2022)
4.2.2 Global Artemisinine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Artemisinine Revenue Market Share by Type (2017-2028)
4.3 Global Artemisinine Price by Type
4.3.1 Global Artemisinine Price by Type (2017-2022)
4.3.2 Global Artemisinine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Artemisinine Sales by Application
5.1.1 Global Artemisinine Historical Sales by Application (2017-2022)
5.1.2 Global Artemisinine Forecasted Sales by Application (2023-2028)
5.1.3 Global Artemisinine Sales Market Share by Application (2017-2028)
5.2 Global Artemisinine Revenue by Application
5.2.1 Global Artemisinine Historical Revenue by Application (2017-2022)
5.2.2 Global Artemisinine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Artemisinine Revenue Market Share by Application (2017-2028)
5.3 Global Artemisinine Price by Application
5.3.1 Global Artemisinine Price by Application (2017-2022)
5.3.2 Global Artemisinine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Artemisinine Market Size by Type
6.1.1 North America Artemisinine Sales by Type (2017-2028)
6.1.2 North America Artemisinine Revenue by Type (2017-2028)
6.2 North America Artemisinine Market Size by Application
6.2.1 North America Artemisinine Sales by Application (2017-2028)
6.2.2 North America Artemisinine Revenue by Application (2017-2028)
6.3 North America Artemisinine Market Size by Country
6.3.1 North America Artemisinine Sales by Country (2017-2028)
6.3.2 North America Artemisinine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Artemisinine Market Size by Type
7.1.1 Europe Artemisinine Sales by Type (2017-2028)
7.1.2 Europe Artemisinine Revenue by Type (2017-2028)
7.2 Europe Artemisinine Market Size by Application
7.2.1 Europe Artemisinine Sales by Application (2017-2028)
7.2.2 Europe Artemisinine Revenue by Application (2017-2028)
7.3 Europe Artemisinine Market Size by Country
7.3.1 Europe Artemisinine Sales by Country (2017-2028)
7.3.2 Europe Artemisinine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Artemisinine Market Size by Type
8.1.1 Asia Pacific Artemisinine Sales by Type (2017-2028)
8.1.2 Asia Pacific Artemisinine Revenue by Type (2017-2028)
8.2 Asia Pacific Artemisinine Market Size by Application
8.2.1 Asia Pacific Artemisinine Sales by Application (2017-2028)
8.2.2 Asia Pacific Artemisinine Revenue by Application (2017-2028)
8.3 Asia Pacific Artemisinine Market Size by Region
8.3.1 Asia Pacific Artemisinine Sales by Region (2017-2028)
8.3.2 Asia Pacific Artemisinine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Artemisinine Market Size by Type
9.1.1 Latin America Artemisinine Sales by Type (2017-2028)
9.1.2 Latin America Artemisinine Revenue by Type (2017-2028)
9.2 Latin America Artemisinine Market Size by Application
9.2.1 Latin America Artemisinine Sales by Application (2017-2028)
9.2.2 Latin America Artemisinine Revenue by Application (2017-2028)
9.3 Latin America Artemisinine Market Size by Country
9.3.1 Latin America Artemisinine Sales by Country (2017-2028)
9.3.2 Latin America Artemisinine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Artemisinine Market Size by Type
10.1.1 Middle East and Africa Artemisinine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Artemisinine Revenue by Type (2017-2028)
10.2 Middle East and Africa Artemisinine Market Size by Application
10.2.1 Middle East and Africa Artemisinine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Artemisinine Revenue by Application (2017-2028)
10.3 Middle East and Africa Artemisinine Market Size by Country
10.3.1 Middle East and Africa Artemisinine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Artemisinine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Guilin Pharmaceutical
11.1.1 Guilin Pharmaceutical Corporation Information
11.1.2 Guilin Pharmaceutical Overview
11.1.3 Guilin Pharmaceutical Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Guilin Pharmaceutical Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Guilin Pharmaceutical Recent Developments
11.2 CAT KHANH
11.2.1 CAT KHANH Corporation Information
11.2.2 CAT KHANH Overview
11.2.3 CAT KHANH Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CAT KHANH Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CAT KHANH Recent Developments
11.3 Novanat Bioresource
11.3.1 Novanat Bioresource Corporation Information
11.3.2 Novanat Bioresource Overview
11.3.3 Novanat Bioresource Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novanat Bioresource Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novanat Bioresource Recent Developments
11.4 BEEPZ
11.4.1 BEEPZ Corporation Information
11.4.2 BEEPZ Overview
11.4.3 BEEPZ Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BEEPZ Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BEEPZ Recent Developments
11.5 KPC Pharmaceuticals
11.5.1 KPC Pharmaceuticals Corporation Information
11.5.2 KPC Pharmaceuticals Overview
11.5.3 KPC Pharmaceuticals Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 KPC Pharmaceuticals Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 KPC Pharmaceuticals Recent Developments
11.6 BIONEXX
11.6.1 BIONEXX Corporation Information
11.6.2 BIONEXX Overview
11.6.3 BIONEXX Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 BIONEXX Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BIONEXX Recent Developments
11.7 Guangxi xiancaotang
11.7.1 Guangxi xiancaotang Corporation Information
11.7.2 Guangxi xiancaotang Overview
11.7.3 Guangxi xiancaotang Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Guangxi xiancaotang Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Guangxi xiancaotang Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Natural Bio-engineering
11.9.1 Natural Bio-engineering Corporation Information
11.9.2 Natural Bio-engineering Overview
11.9.3 Natural Bio-engineering Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Natural Bio-engineering Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Natural Bio-engineering Recent Developments
11.10 Kerui nanhai
11.10.1 Kerui nanhai Corporation Information
11.10.2 Kerui nanhai Overview
11.10.3 Kerui nanhai Artemisinine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Kerui nanhai Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Kerui nanhai Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Artemisinine Industry Chain Analysis
12.2 Artemisinine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Artemisinine Production Mode & Process
12.4 Artemisinine Sales and Marketing
12.4.1 Artemisinine Sales Channels
12.4.2 Artemisinine Distributors
12.5 Artemisinine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Artemisinine Industry Trends
13.2 Artemisinine Market Drivers
13.3 Artemisinine Market Challenges
13.4 Artemisinine Market Restraints
14 Key Findings in The Global Artemisinine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Artemisinine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Extraction from Artemisia annua
Table 3. Major Manufacturers of Semisynthetic Artemisinine
Table 4. Global Artemisinine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Artemisinine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Artemisinine Sales by Region (2017-2022) & (K Units)
Table 7. Global Artemisinine Sales Market Share by Region (2017-2022)
Table 8. Global Artemisinine Sales by Region (2023-2028) & (K Units)
Table 9. Global Artemisinine Sales Market Share by Region (2023-2028)
Table 10. Global Artemisinine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Artemisinine Revenue Market Share by Region (2017-2022)
Table 12. Global Artemisinine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Artemisinine Revenue Market Share by Region (2023-2028)
Table 14. Global Artemisinine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Artemisinine Sales Share by Manufacturers (2017-2022)
Table 16. Global Artemisinine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Artemisinine Revenue Share by Manufacturers (2017-2022)
Table 18. Artemisinine Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Artemisinine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Artemisinine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinine as of 2021)
Table 21. Artemisinine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Artemisinine Product Offered
Table 23. Date of Manufacturers Enter into Artemisinine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Artemisinine Sales by Type (2017-2022) & (K Units)
Table 26. Global Artemisinine Sales by Type (2023-2028) & (K Units)
Table 27. Global Artemisinine Sales Share by Type (2017-2022)
Table 28. Global Artemisinine Sales Share by Type (2023-2028)
Table 29. Global Artemisinine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Artemisinine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Artemisinine Revenue Share by Type (2017-2022)
Table 32. Global Artemisinine Revenue Share by Type (2023-2028)
Table 33. Artemisinine Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Artemisinine Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Artemisinine Sales by Application (2017-2022) & (K Units)
Table 36. Global Artemisinine Sales by Application (2023-2028) & (K Units)
Table 37. Global Artemisinine Sales Share by Application (2017-2022)
Table 38. Global Artemisinine Sales Share by Application (2023-2028)
Table 39. Global Artemisinine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Artemisinine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Artemisinine Revenue Share by Application (2017-2022)
Table 42. Global Artemisinine Revenue Share by Application (2023-2028)
Table 43. Artemisinine Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Artemisinine Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Artemisinine Sales by Type (2017-2022) & (K Units)
Table 46. North America Artemisinine Sales by Type (2023-2028) & (K Units)
Table 47. North America Artemisinine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Artemisinine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Artemisinine Sales by Application (2017-2022) & (K Units)
Table 50. North America Artemisinine Sales by Application (2023-2028) & (K Units)
Table 51. North America Artemisinine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Artemisinine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Artemisinine Sales by Country (2017-2022) & (K Units)
Table 54. North America Artemisinine Sales by Country (2023-2028) & (K Units)
Table 55. North America Artemisinine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Artemisinine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Artemisinine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Artemisinine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Artemisinine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Artemisinine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Artemisinine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Artemisinine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Artemisinine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Artemisinine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Artemisinine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Artemisinine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Artemisinine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Artemisinine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Artemisinine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Artemisinine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Artemisinine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Artemisinine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Artemisinine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Artemisinine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Artemisinine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Artemisinine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Artemisinine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Artemisinine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Artemisinine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Artemisinine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Artemisinine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Artemisinine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Artemisinine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Artemisinine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Artemisinine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Artemisinine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Artemisinine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Artemisinine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Artemisinine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Artemisinine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Artemisinine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Artemisinine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Artemisinine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Artemisinine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Artemisinine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Artemisinine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Artemisinine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Artemisinine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Artemisinine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Artemisinine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Artemisinine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Artemisinine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Artemisinine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Artemisinine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Guilin Pharmaceutical Corporation Information
Table 106. Guilin Pharmaceutical Description and Major Businesses
Table 107. Guilin Pharmaceutical Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Guilin Pharmaceutical Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Guilin Pharmaceutical Recent Developments
Table 110. CAT KHANH Corporation Information
Table 111. CAT KHANH Description and Major Businesses
Table 112. CAT KHANH Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. CAT KHANH Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. CAT KHANH Recent Developments
Table 115. Novanat Bioresource Corporation Information
Table 116. Novanat Bioresource Description and Major Businesses
Table 117. Novanat Bioresource Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Novanat Bioresource Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Novanat Bioresource Recent Developments
Table 120. BEEPZ Corporation Information
Table 121. BEEPZ Description and Major Businesses
Table 122. BEEPZ Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. BEEPZ Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. BEEPZ Recent Developments
Table 125. KPC Pharmaceuticals Corporation Information
Table 126. KPC Pharmaceuticals Description and Major Businesses
Table 127. KPC Pharmaceuticals Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. KPC Pharmaceuticals Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. KPC Pharmaceuticals Recent Developments
Table 130. BIONEXX Corporation Information
Table 131. BIONEXX Description and Major Businesses
Table 132. BIONEXX Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. BIONEXX Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. BIONEXX Recent Developments
Table 135. Guangxi xiancaotang Corporation Information
Table 136. Guangxi xiancaotang Description and Major Businesses
Table 137. Guangxi xiancaotang Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Guangxi xiancaotang Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Guangxi xiancaotang Recent Developments
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Major Businesses
Table 142. Sanofi Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Sanofi Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Sanofi Recent Developments
Table 145. Natural Bio-engineering Corporation Information
Table 146. Natural Bio-engineering Description and Major Businesses
Table 147. Natural Bio-engineering Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Natural Bio-engineering Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Natural Bio-engineering Recent Developments
Table 150. Kerui nanhai Corporation Information
Table 151. Kerui nanhai Description and Major Businesses
Table 152. Kerui nanhai Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Kerui nanhai Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Kerui nanhai Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Artemisinine Distributors List
Table 158. Artemisinine Customers List
Table 159. Artemisinine Market Trends
Table 160. Artemisinine Market Drivers
Table 161. Artemisinine Market Challenges
Table 162. Artemisinine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Artemisinine Product Picture
Figure 3. Global Artemisinine Market Share by Type in 2021 & 2028
Figure 3. Extraction from Artemisia annua Product Picture
Figure 4. Semisynthetic Artemisinine Product Picture
Figure 5. Global Artemisinine Market Share by Application in 2021 & 2028
Figure 6. Injections
Figure 7. Tablets
Figure 8. Others
Figure 9. Artemisinine Report Years Considered
Figure 10. Global Artemisinine Sales 2017-2028 (K Units)
Figure 11. Global Artemisinine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Artemisinine Revenue 2017-2028 (US$ Million)
Figure 13. Global Artemisinine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Artemisinine Sales Market Share by Region (2017-2022)
Figure 15. Global Artemisinine Sales Market Share by Region (2023-2028)
Figure 16. North America Artemisinine Sales YoY (2017-2028) & (K Units)
Figure 17. North America Artemisinine Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Artemisinine Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Artemisinine Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Artemisinine Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Artemisinine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Artemisinine Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Artemisinine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Artemisinine Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Artemisinine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Artemisinine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Artemisinine in the World: Market Share by Artemisinine Revenue in 2021
Figure 28. Global Artemisinine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Artemisinine Sales Market Share by Type (2017-2028)
Figure 30. Global Artemisinine Revenue Market Share by Type (2017-2028)
Figure 31. Global Artemisinine Sales Market Share by Application (2017-2028)
Figure 32. Global Artemisinine Revenue Market Share by Application (2017-2028)
Figure 33. North America Artemisinine Sales Market Share by Type (2017-2028)
Figure 34. North America Artemisinine Revenue Market Share by Type (2017-2028)
Figure 35. North America Artemisinine Sales Market Share by Application (2017-2028)
Figure 36. North America Artemisinine Revenue Market Share by Application (2017-2028)
Figure 37. North America Artemisinine Sales Share by Country (2017-2028)
Figure 38. North America Artemisinine Revenue Share by Country (2017-2028)
Figure 39. U.S. Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Artemisinine Sales Market Share by Type (2017-2028)
Figure 42. Europe Artemisinine Revenue Market Share by Type (2017-2028)
Figure 43. Europe Artemisinine Sales Market Share by Application (2017-2028)
Figure 44. Europe Artemisinine Revenue Market Share by Application (2017-2028)
Figure 45. Europe Artemisinine Sales Share by Country (2017-2028)
Figure 46. Europe Artemisinine Revenue Share by Country (2017-2028)
Figure 47. Germany Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 48. France Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Artemisinine Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Artemisinine Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Artemisinine Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Artemisinine Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Artemisinine Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Artemisinine Revenue Share by Region (2017-2028)
Figure 58. China Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 61. India Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Artemisinine Sales Market Share by Type (2017-2028)
Figure 69. Latin America Artemisinine Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Artemisinine Sales Market Share by Application (2017-2028)
Figure 71. Latin America Artemisinine Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Artemisinine Sales Share by Country (2017-2028)
Figure 73. Latin America Artemisinine Revenue Share by Country (2017-2028)
Figure 74. Mexico Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Artemisinine Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Artemisinine Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Artemisinine Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Artemisinine Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Artemisinine Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Artemisinine Revenue Share by Country (2017-2028)
Figure 83. Turkey Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Artemisinine Revenue (2017-2028) & (US$ Million)
Figure 86. Artemisinine Value Chain
Figure 87. Artemisinine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
